Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

1 Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan 2 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada Data ...

Illumina, Inc. ILMN has announced a collaboration with NVIDIA NVDA to advance technology platforms for analyzing and interpreting multiomic data. By combining advancements in artificial ...

NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...